Explore UAB


In recognition of Ms. Tulcin’s leadership in CF advocacy, the University of Alabama Board of Trustees established the D. F. Tulcin Research Award. Selection is made by the Cystic Fibrosis Foundation, but funded through an endowment established at UAB. This national honorary event highlights the very best in CF research.

Doris Tulcin spent her entire professional career both as volunteer and staff member working toward the universal mission of  control and cure for cystic fibrosis. She has undertaken many responsibilities within CFF: National President for three terms; National Campaign Chairman to raise $28 million to support the Research Development Centers Program; serving on the NHLBI Advisory Council at NIH for 2 terms; and retiring as Director following 18 years of service to the Greater New York Chapter for the CF Foundation. In tribute to her many years of leadership and service, the CF Foundation has dedicated a major gift effort in her name known as the Doris F. Tulcin Major Gifts Society.

Symposium Presentation
Paul M. Quinton, PhD University of California, Riverside Passage of Chloride through Tight Junctions of Sweat Glands
Raymond A. Frizzell, PhD University of Alabama at Birmingham The Chloride Transport Defect in Cystic Fibrosis
Richard C. Boucher, MD University of North Carolina, Chapel Hill Cystic Fibrosis: From Patients, to Bench, to Patients
Lap-Chee Tsui, PhD University of Toronto Molecular Genetics of Cystic Fibrosis
Michael J. Welsh, MD  HHMI/University of Iowa Cystic Fibrosis and CFTR
Bonnie W. Ramsey, MD University of Washington, Seattle New Clinical Developments in Cystic Fibrosis: From the Test Tube to the Bedside
Frank J. Accurso, MD University of Colorado, Denver Early Diagnosis and Treatment of Cystic Fibrosis
William B. Guggino, PhD Johns Hopkins University The Promise of a Gene Therapy for CF. Where Are We Now?
Pamela B. Davis, MD, PhD Case Western Reserve University Gene Therapy for CF-Hope or Hype?
Michael R. Knowles, MD University of North Carolina, Chapel Hill Cystic Fibrosis: Then, Now, and Future
Fred Van Goor, PhD Vertex Pharmaceuticals Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis